期刊文献+

芳香化酶抑制剂对大鼠子宫内膜异位灶中生存素及Caspase-3的影响 被引量:3

Effects of Aromatase Inhibitor on Expressions of Survivin and Caspase-3 in the Ectopic Focus of Rat Model with Endometriosis
下载PDF
导出
摘要 目的:探讨芳香化酶抑制剂对子宫内膜异位灶中生存素(Survivin)及半胱氨酸天冬氨酸蛋白酶-3(Caspase-3)表达的影响。方法:采用自体子宫内膜移植法建立大鼠子宫内膜异位症(EMs)模型,造模3周后开腹观察、测量异位灶形态及大小,计算体积,将成模大鼠随机分为来曲唑治疗组(A组)及模型对照组(B组),每组20只。给药4周后处死,观察并测量2组异位灶形态、大小,及2组异位内膜及正常内膜组(C组)的内膜组织学形态,并采用免疫组化法检测Survivin及Caspase-3表达情况。结果:给药4周后,A组异位灶较给药前减小(P<0.05);Survivin及Caspase-3均在内膜腺上皮细胞表达,定位于细胞浆。Survivin在A组及C组的阳性率均低于B组(均P<0.01),Caspase-3在A组及C组的阳性率均高于B组(均P<0.01),而Survivin及Caspase-3在A组与C组阳性率差别无统计学意义(P>0.05)。异位灶中Survivin与Caspase-3的表达呈负相关(rs=-0.538,P<0.05)。结论:芳香化酶抑制剂可抑制大鼠EMs病灶的生长,并抑制异位灶中Survivin的表达,增加Caspase-3的表达。 Objective: To explore the effect of aromatase inhibitor on the expressions of Survivin and Caspase-3 in ectopic focus of rat model. Methods: The rat model of endometriosis(EMs)was made by autologous transplantation of endometrium. The shape and size of the ectopic foci in abdominal cavity were observed and measured after 3 weeks. Rats were then randomly divided into two groups ( twenty in each), letrozole group(A group)and model group as the control (B group). After 4 weeks of administration, the endometrial histological changes were observed in A group, B group and the normal endometrium group (C group). The expression levels of Survivin and Caspase-3 were assessed by immunohistochemical staining in ectopic endometrium and normal endometrium. Results: The rat model of EMs was successfully established. The size of ectopic focus was significantly reduced after 4 weeks of treatment compared with that of before treatment in A group(P〈0.05). Both Survivin and Caspase-3 were expressed in endometrial glandular epithelial cells, locating in cytoplasm. Results showed that the positive rate of Survivin was lower in A group and C group than that of B group (P〈0.01). The positive rate of Caspase-3 was higher in A group and C group than that of B group (P〈0.01), but there was no significant difference in positive rates of Survivin and Caspase-3 between A group and C group (P〉0.05). The expression of Survivin was negatively correlated with that of Caspase-3(rs =-0.538,P〈0.05). Conclusion: The aromatase inhibitor can inhibit the growth of ectopic focus and Survivin expression, and increase the expression of Caspase-3 in rat ectopic endometrial lesions. The results may offer theoretical foundation for clinical application of letrozole in treatment of EMs.
出处 《天津医药》 CAS 北大核心 2011年第3期260-263,292,共5页 Tianjin Medical Journal
关键词 子宫内膜异位症 芳香酶抑制剂 雌激素类 半胱氨酸天冬氨酸蛋白酶3 疾病模型 动物 大鼠 Sprague-Dawley 生存素 endometriosis aromatase inhibitors estrogens Caspase 3 disease models animal rats Sprague-Dawley survivin
  • 相关文献

参考文献9

  • 1Lebovic DI, Mueller MD, Taylor RN.Immunobiology of endometriosis [J].Fertil Steril, 2001,75(1) : 1-10.
  • 2Fang Z, Yang S, Tamura M, et al. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue[J].J Clin Endocrinol Metab, 2002,87(7) : 3460-3466.
  • 3Boccardo F, Rubagotti A, Aldrighetti D, et al. Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials[J].Cancer, 2007, 109 (6) : 1060-1067.
  • 4Gibson L J, Dawson CK, Lawrence DH, et al.Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women[J].Cochrane Database Syst Rev, 2007,24( 1 ) : CD003370.
  • 5Meresman GF, Bilotas M, Abello V, et al.Effects of ammatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis[J].Fertil Steril, 2005,84(2) : 459-463.
  • 6Dheenadayalu K, Mak I, Gordts S, et al.Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis[J].Fertil Steril, 2002,78(4): 825-829.
  • 7Bulun SE, Fang Z, Imir G, et al.Aromatase and endometriosis[J]. Semin Reprod Med, 2004,22(1) : 45-50.
  • 8Kawasaki H, Toyoda M, Shinohara H ,et al. Expression of Survivin correlates apoptosis proliferation, and angiogenesis during human colorectal tumorigenesis[J]. Cancer ,2001,91 (11 ) :2026-2032.
  • 9Tamm I ,Wang Y, Sausville E,et al.IAP-family protein survivin in- hibits easpase activity and apoptosis induced by Fas ( CD95),Bax, easpases,and antieaneer drugs[J].Cancer Res,1998,58(23):5315-5320.

同被引文献46

  • 1陈颖,阴春霞,郑莹.促性腺激素释放激素激动剂治疗子宫内膜异位症的临床研究[J].中国妇幼保健,2007,22(25):3503-3504. 被引量:22
  • 2肖承棕.中医妇科临床研究[M].北京:人民卫生出版社,2009:89.
  • 3Ghosh D, Griswold J, Erman M, et al. Structural basis for androgen specificity and oestrogen synthesis in human aro- matase. Nature, 2009, 457.. 219-223.
  • 4Hong Y, Li H, Yuan YC, et al. Molecular characterization o aromatase Ann N Y Acad Sci, 2009, 1155 ." 112 - 120.
  • 5Ishikawa H, Reierstad S, Demura M, et al. High aromatase expression in uterine leiomyoma tissues of African - American women. Clin Endocrinol Metab, 2009, 94: 1752- 1756.
  • 6Gurates B, Parmaksiz C, Kilic G, et al. Treatment of symp- tomatic uterine leiomyoma with letrozole. Reprod Biomed Online, 2008, 17.. 569-574.
  • 7Hilfirio SG, Bozzini N, Borsari R, et al. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patient Fertil Sterit, 2009, 91.. 240-243.
  • 8Balakrishnan A, Ravichandran D. Early operable breast canc- er in elderly women treated with an aromatase inhibitor letro zole as sole therapy. Br J Cancer, 2011, 105:1825 - 1829.
  • 9Tehrani SH Nejad E, Abediasl Z. et al, Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen cit- rate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. Assist Reprod Genet, 2008, 25: 187-190.
  • 10Ganesh A, Goswami SK, Chattopadhyay R, et al. Compari- son of letrozole with continuous gonadotropins and clomi- phene- gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a ran- domized prospective clinical trial. J Assist Reprod Genet, 2009, 26: 19-24.

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部